乙基仲丁基硫醚 | 5008-72-0

• 物质功能分类: 化学试剂 - 有机试剂 - 硫醇/硫酚
• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 中文名称: 乙基仲丁基硫醚
• 英文名称: Aethyl-sec-butyl-sulfid
• 英文别名: 2-(Ethylthio)butane；2-ethylsulfanylbutane
• CAS: 5008-72-0
• 化学式: C₆H₁₄S
• mdl: MFCD00039924
• 分子量: 118.243
• InChiKey: JFNGZXUPUVUYST-UHFFFAOYSA-N

物化性质

• 熔点：
  -96.69°C (estimate)
• 沸点：
  133.65°C
• 密度：
  0.831
• LogP：
  3.010 (est)
• 保留指数：
  850;841;850;850

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  7
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2930909090

反应信息

• 作为反应物：
  描述：

  乙基仲丁基硫醚 在 水 、 双氧水 、 溶剂黄146 作用下， 生成 Ethyl-sec.butylsulfon
  参考文献：
  名称：

  The Preparation and Properties of Sulfur Compounds Related to Petroleum. I. The Dialkyl Sulfides and Disulfides¹

  摘要：

  DOI：

  10.1021/ja01152a021
• 作为产物：
  描述：

  2,2-Bis-ethylmercapto-butan 在 cobalt polysulfide 作用下， 生成 乙基仲丁基硫醚
  参考文献：
  名称：

  US2402614

  摘要：

  公开号：

文献信息

• HETEROCYCLIC TRPV1 RECEPTOR LIGANDS
  申请人：Tafesse Laykea

  公开号：US20100137306A1

  公开（公告）日：2010-06-03

  The invention relates to compounds of formulae I(a)-I(d): and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formulae I(a)-I(d) or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formulae I(a)-I(d) or a pharmaceutically acceptable derivative thereof.

  该发明涉及以下化合物的化学式：I(a)-I(d)，及其药学上可接受的衍生物，包括含有化合物I(a)-I(d)或其药学上可接受的衍生物的有效量的组合物，以及用于治疗或预防疼痛、尿失禁、溃疡、炎症性肠病和肠易激综合征等疾病的方法，包括向需要的动物施用化合物I(a)-I(d)或其药学上可接受的衍生物的有效量。
• Alkoxy- and Alkylthio-Substituted Anilinopyrimidines
  申请人：Greul Jörg Nico

  公开号：US20110245284A1

  公开（公告）日：2011-10-06

  Alkoxy- and alkylthio-substituted anilinopyrimidines of the formula (I) in which R 1 to R 14 and E1, E2, E3, X and Y have the meanings given in the description, and agrochemically active salts thereof, their use, and methods and compositions for controlling phytopathogenic harmful fungi in and/or on plants or in and/or on seeds of plants, processes for preparing such compositions and treated seeds and also their use for controlling phytopathogenic hal inful fungi in agriculture, horticulture and forestry, in the protection of materials and in the domestic and hygiene field. The present invention furthermore relates to a process for the preparation of alkoxy- and alkylthio-substituted anilinopyrimidines of the formula (I).

  配方（I）中的烷氧基和烷硫基取代的苯胺嘧啶化合物，其中R1至R14和E1、E2、E3、X和Y的含义如描述中所示，以及其农用活性盐、它们的用途，用于控制植物或种子中和/或上的植物病原有害真菌的方法和组合物，用于制备这种组合物的过程和处理过的种子，以及它们在农业、园艺和林业中控制植物病原有害真菌、保护材料以及在家庭和卫生领域中的用途。本发明还涉及一种制备配方（I）中的烷氧基和烷硫基取代的苯胺嘧啶化合物的方法。
• Thiazolyl mglur5 antagonists and methods for their use
  申请人：Cosford Nicholas D.

  公开号：US20090203903A1

  公开（公告）日：2009-08-13

  The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.

  一系列独特化合物的鉴定，由于它们在药物样性方面具有优势特性，包括在效力、药代动力学、选择性和体内受体占有性质方面具有优势特性。具体来说，选择一个由乙炔基连接到吡啶环的3位或嘧啶环的5位的1,3-噻唑-2-基环成员，其中环被选定取代基取代，将导致一种具有优越药物样性的化合物。该发明包括这些杂环化合物的药用盐形式，特别是氯化盐和三氟乙酸盐。
• Nitrogen containing heterocyclic compounds and medicines containing the same
  申请人：Ozaki Fumihiro

  公开号：US20070293496A1

  公开（公告）日：2007-12-20

  Compounds represented by the following general formula: [wherein X 1 , X 2 , X 3 and X 4 each independently represent a single bond, C 1-6 alkylene, etc.; A 2 represents optionally substituted phenyl, etc.; A 1 represents an optionally substituted 5- to 7-membered heterocyclic group containing —C(=Q 1 )- (wherein Q 1 represents oxygen, sulfur or ═N—R 11 (wherein R 11 represents hydrogen or C 1-6 alkyl)) and nitrogen, etc.; and Z 1 represents piperidin-diyl, etc.], salts thereof and hydrates of the foregoing.

  以下一般式所代表的化合物：[其中X1、X2、X3和X4各自独立地代表单键、C1-6烷基等；A2代表可选取代的苯基等；A1代表可选取代的5-至7-成员杂环基，其中包含—C（=Q1）-（其中Q1代表氧、硫或═N—R11（其中R11代表氢或C1-6烷基））和氮等；Z1代表哌啶基等]，其盐和水合物。
• Thiazolyl Mglur5 Antagonists and Methods for Their Use
  申请人：Cosford Nicholas D.

  公开号：US20110230526A1

  公开（公告）日：2011-09-22

  The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.

  本发明涉及一系列独特的化合物，由于它们具有优越的药物特性，因此具有优越的药物特性，包括效力和/或药代动力学和/或选择性和/或体内受体占有率特性。具体来说，选择一个1,3-噻唑-2-基环成员，通过乙炔基连接到吡啶环的3位或嘧啶环的5位，其中该环被选定的取代基取代，结果产生具有优越药物特性的化合物。本发明包括这些杂环化合物的药学上可接受的盐形式，特别是氯化物盐和三氟乙酸盐。

表征谱图